Change in treatment adherence after three months of treatment with extrafine formulation single-inhaler triple therapy in patients with asthma: the TriMaximize study

被引：0
|
作者：
Trinkmann, Frederik [1 ]
Akyildiz, Berktan [2 ]
Ulrik, Charlotte Suppli [3 ]
Nachtigall, Detlef [2 ]
Pohl, Wolfgang [4 ]
Bogoevska, Valentina [5 ]
Russell, Richard [6 ]
Grickschat, Veronika [7 ]
Gessner, Christian [8 ]
机构：
[1] Heidelberg Univ Hosp, Thoraxklin, Heidelberg, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Copenhagen Univ Hosp Hvidovre, Dept Pulm Med, Copenhagen, Germany
[4] Vienna Healthcare Grp, Karl Landsteiner Inst Clin & Expt Pneumol, Clin Hietzing, Vienna, Austria
[5] Chiesi GmbH Hamburg, Vienna, Austria
[6] Univ Oxford, Oxford, England
[7] Chiesi GmbH Hamburg, Hamburg, Germany
[8] Pneumol Praxis Leipzig, Leizipg, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2376
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study
    Greulich, Timm
    Bogoevska, Valentina
    Nachtigall, Detlef
    Russell, Richard
    Suppli, Charlotte
    Wolfgang, Ulrik
    Pohl, Wolfgang
    Plaza, Vicente
    Bourdin, Arnaud
    Baumeister, Soeren
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Impact of extrafine formulation single-inhaler triple therapy on lung function after three months of treatment in patients with asthma: the TriMaximize study
    Gessner, Christian
    Akyildiz, Berktan
    Russell, Richard
    Nachtigall, Detlef
    Ulrik, Charlotte Suppli
    Bogoevska, Valentina
    Pohl, Wolfgang
    Licht, Bjoern
    Criee, Carl-Peter
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Effect on asthma control in patients with asthma and concomitant COPD after three months of treatment with extrafine formulation single-inhaler triple therapy TriMaximize study
    Timmermann, Hartmut
    Akyildiz, Berktan
    Bogoevska, Valentina
    Russell, Richard
    Nachtigall, Detlef
    Pohl, Wolfgang
    Ulrik, Charlotte Suppli
    Wendt, Andreas
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study
    Gessner, C.
    Bogoevska, V.
    Nachtigall, D.
    Russell, R.
    Ulrik, C. S.
    Pohl, W.
    Plaza, V.
    Bourdin, A.
    Akyildiz, B.
    Trinkmann, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] Impact of extrafine formulation single-inhaler triple therapy on health-related quality of life after three months of treatment in patients with asthma: the TriMaximize study
    Koczulla, Rembert
    Akyildiz, Berktan
    Ulrik, Charlotte Suppli
    Nachtigall, Detlef
    Russell, Richard
    Bogoevska, Valentina
    Pohl, Wolfgang
    Borucki, Tanja
    Martini, Maurice-Dominique
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study
    Gessner, Christian
    Bogoevska, Valentina
    Nachtigall, Detlef
    Russell, Richard
    Ulrik, Charlotte Suppli
    Pohl, Wolfgang
    Plaza, Vicente
    Bourdin, Arnaud
    Criee, Carl-Peter
    Trinkmann, Frederik
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] Change in asthma control after three months of treatment with extrafine formulation singleinhaler triple therapy in patients with asthma: the TriMaximize study
    Greulich, Timm
    Akyildiz, Berktan
    Pohl, Wolfgang
    Nachtigall, Detlef
    Russell, Richard
    Bogoevska, Valentina
    Ulrik, Charlotte Suppli
    Slawinska, Renata
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment TriMaximize Study
    Gessner, C.
    Bogoevska, V
    Nachtigall, D.
    Akyildiz, B.
    Martini, M.
    Wendt, A.
    Criee, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [9] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [10] Treatment with extrafine formulation single-inhaler triple therapy improves disease control and adherence in patients with asthma - a 3-month interim analysis from the TriMaximize UK study
    Richards, J.
    Rangwani, N.
    Russell, R.
    THORAX, 2023, 78 (SUPPL_4) : A83 - A84
12345